Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)

CAPS Rating: 2 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Recs

0
Player Avatar englishdk (< 20) Submitted: 12/7/2011 7:50:24 AM : Underperform Start Price: $2.57 CYTX Score: +20.15

stem cells dont work

Featured Broker Partners


Advertisement